To address the ongoing threats from New World screwworm, the Foundation for Food & Agriculture Research (FFAR) and Medgene are investing $499,996 in a Rapid Outcomes from Agricultural Research (ROAR) grant to develop and test a vaccine that could help protect cattle from this harmful parasite.
Why it matters:
New World screwworm is a parasitic fly whose larvae feed on the living tissue of livestock, wildlife, pets and humans. Infestations can be severe and potentially fatal. Female flies can lay up to 400 eggs at a single site, and with a life cycle of about 15 days, the parasite can spread rapidly without effective controls.
The research:
Led by Dr. Casey Wright, bacteriology development manager at Medgene, researchers are developing a vaccine that targets proteins New World screwworm larvae need to feed and develop. The goal is to trigger antibodies in vaccinated cattle that interfere with the larvae’s ability to feed on tissue and complete their life cycle.
Using Medgene’s scalable vaccine production platform, the team is vaccinating cattle, assessing safety and measuring their immune response to determine whether the vaccine should advance to field studies.
The potential:
If successful, the vaccine could give producers another tool to protect cattle and limit New World screwworm’s spread. A vaccine could be particularly valuable in extensive production systems, where livestock are dispersed across large areas and frequent monitoring and treatment can be challenging. The approach would complement the sterile insect release program and other control measures by preventing larvae from successfully feeding and developing in cattle.
This research supports U.S. Department of Agriculture’s research priority on Protecting the Integrity of American Agriculture from Invasive Species.